Skip to main navigation

Investor Relations

Overview
News & Events
Stock Information
Financial Information
Corporate Governance
Investor Resources

Press Releases

Press Releases

Year

Nov 24, 2020

Applied Molecular Transport to Present at Evercore ISI 3rd Annual HealthCONx Conference

Nov 12, 2020

Applied Molecular Transport Reports Third Quarter 2020 Financial Results and Provides Corporate Update

Nov 11, 2020

Applied Molecular Transport to Present at Jefferies Virtual London Healthcare Conference

Nov 10, 2020

Applied Molecular Transport Announces Publication of Preclinical Data Demonstrating Potential of Novel Oral IL-10 Biologic Therapeutic (AMT-101) for Inflammatory Diseases in The Journal of Immunology

Sep 22, 2020

Applied Molecular Transport to Present at Jefferies Next Generation IBD Therapeutics Virtual Summit

Aug 27, 2020

Applied Molecular Transport Announces First Patient Dosed in Phase 2 Study of Oral AMT-101 in Ulcerative Colitis

Aug 11, 2020

Applied Molecular Transport Reports Second Quarter 2020 Financial Results

Aug 05, 2020

Applied Molecular Transport Named as One of Three Finalists for the Fierce Innovations Awards for AMT-101

Jun 09, 2020

Applied Molecular Transport Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares

Jun 04, 2020

Applied Molecular Transport Announces Pricing of Initial Public Offering

Pagination

Current page 1
Page 2
Next page
Last page

Displaying 1 - 10 of 12

Investor Tools

Applied | Molecular | Transport

Copyright © Applied Molecular Transport Inc. 2020. All rights reserved.